8th RSC-BMCS Fragment-based Drug Discovery Meeting, Cambridge

Red Glead Discovery will attend the 8th RSC-BMC Fragment-based Drug Discovery Meeting in Cambridge on 27-29th of March. Our head of Fragment Screening, Dr Kirill Popov give a flash presentation for our poster titled “Exploring the bromodomain of SMARCA4 (BRG1) by Weak Affinity Chromatography (WAC™). We will showcase our (co-owned with Saromics Biostructures) fragment-based screening platform that allows us to perform hit finding, validation and expansion rapidly and efficiently for a wide variety of biological targets.

Fragment-based Drug Discovery – RSC BMCS